Literature DB >> 11075634

A delphi approach to characterising "relapse" as used in UK clinical practice.

T Burns1, M Fiander, B Audini.   

Abstract

BACKGROUND: 'Relapse' is a common outcome indicator in intervention studies in schizophrenia. In community studies it is frequently equated with hospitalisation and in psychopharmacological studies with predetermined symptom scores. Its clinical meaning, however, remains undefined.
METHOD: Consensus on the defining features of 'relapse' in schizophrenia used by academic and clinical schizophrenia experts in the UK, was investigated using a four stage Delphi process. A two panel, four stage, Delphi based methodology was used to investigate the implicit meanings of 'relapse' in clinical practice. A multidisciplinary panel of twelve members each listed anonymously ten indicators of relapse. A second panel, of ten experienced psychiatrists, rated the 188 submitted indicators from essential-unimportant (1-5). This panel completed a one day workshop during the remaining Delphi rounds ending with a structured discussion of the results.
RESULTS: Very strong consensus was achieved on the relative importance of potential relapse indicators. There was complete agreement about some aspects of a definition of relapse (such as recurrence of positive symptoms) and a number of the complex issues underlying the concept were clearly articulated.
CONCLUSIONS: This four stage Delphi process achieved consensus on core features of relapse. The elucidation of the "softer" features at the threshold between normal fluctuations in functioning and the start of relapse require continuing investigations.

Entities:  

Mesh:

Year:  2000        PMID: 11075634     DOI: 10.1177/002076400004600308

Source DB:  PubMed          Journal:  Int J Soc Psychiatry        ISSN: 0020-7640


  9 in total

1.  What are the components of CBT for psychosis? A Delphi study.

Authors:  Anthony P Morrison; Sarah Barratt
Journal:  Schizophr Bull       Date:  2009-10-30       Impact factor: 9.306

2.  Recovery in psychosis: a Delphi study with experts by experience.

Authors:  Heather Law; Anthony P Morrison
Journal:  Schizophr Bull       Date:  2014-04-12       Impact factor: 9.306

3.  Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis.

Authors:  Dee Lin; Philippe Thompson-Leduc; Isabelle Ghelerter; Ha Nguyen; Marie-Hélène Lafeuille; Carmela Benson; Panagiotis Mavros; Patrick Lefebvre
Journal:  CNS Drugs       Date:  2021-04-28       Impact factor: 5.749

4.  Defining outcome measures of hospitalization for assessment in the Japanese forensic mental health scheme: a Delphi study.

Authors:  Akihiro Shiina; Masaomi Iyo; Yoshito Igarashi
Journal:  Int J Ment Health Syst       Date:  2015-01-28

5.  Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis.

Authors:  Marie-Hélène Lafeuille; François Laliberté-Auger; Patrick Lefebvre; Christian Frois; John Fastenau; Mei Sheng Duh
Journal:  BMC Psychiatry       Date:  2013-09-10       Impact factor: 3.630

6.  Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study.

Authors:  Flore Decuypere; Jan Sermon; Paul Geerts; Tom R Denee; Cedric De Vos; Bart Malfait; Mark Lamotte; Cornelis L Mulder
Journal:  PLoS One       Date:  2017-06-14       Impact factor: 3.240

7.  Effect of long-acting injectable antipsychotics on hospitalizations and global functioning in schizophrenia: a naturalistic mirror-image study.

Authors:  Cristiana Montemagni; Elisa Del Favero; Elena Cocuzza; Flavio Vischia; Paola Rocca
Journal:  Ther Adv Psychopharmacol       Date:  2022-10-08

8.  Essential elements of an early intervention service for psychosis: the opinions of expert clinicians.

Authors:  Max Marshall; Austin Lockwood; Shôn Lewis; Matthew Fiander
Journal:  BMC Psychiatry       Date:  2004-07-01       Impact factor: 3.630

9.  Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review.

Authors:  José M Olivares; Jan Sermon; Michiel Hemels; Andreas Schreiner
Journal:  Ann Gen Psychiatry       Date:  2013-10-23       Impact factor: 3.455

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.